Executive Director, Investor Relations
Entrada Therapeutics
About this role
Entrada Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines that target previously inaccessible intracellular targets, with a portfolio including genetic medicines for neuromuscular and retinal diseases, and collaborations on treatments for Duchenne muscular dystrophy and myotonic dystrophy. The company emphasizes transformation in patient care and is preparing for multiple clinical data readouts through 2026.
Skills
Qualifications
About Entrada Therapeutics
entradatx.comEntrada Therapeutics is a biotechnology company focused on enabling intracellular therapeutics by solving the problem of getting large molecules into cells to reach intracellular targets. They develop proprietary delivery technologies intended to expand access to previously “undruggable” intracellular targets and transform treatment options for devastating genetic and other diseases. Entrada advances its own therapeutic programs and collaborates with partners to translate its platform into clinically meaningful medicines.
Recent company news
MarketBeatEntrada Therapeutics (NASDAQ:TRDA) Hits New 1-Year High - Time to Buy?
2 days ago
Finviz - Stock ScreenerEarnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline
3 weeks ago
The Globe and MailAnalysts Offer Insights on Healthcare Companies: Entrada Therapeutics Inc (TRDA), Kymera Therapeutics (KYMR) and Argenx Se (ARGX)
2 weeks ago
Yahoo FinanceEntrada Therapeutics, Inc. (TRDA) Reports Q3 Loss, Misses Revenue Estimates
Nov 6, 2025
MarketBeatInsider Selling: Entrada Therapeutics (NASDAQ:TRDA) COO Sells 3,116 Shares of Stock
1 day ago
About Entrada Therapeutics
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Entrada Therapeutics.
Salary
$292k – $395k
per year
More jobs at Entrada Therapeutics
Similar Jobs
Associate Director, Clinical Operations Lead
Sarepta Therapeutics
Patient Affairs Intern
Sarepta Therapeutics
Executive Medical Director, Pharmacovigilance
Sarepta Therapeutics
Director, Corporate Strategy
Sarepta Therapeutics
Machine Learning Scientist, Oligo Research Intern
Sarepta Therapeutics
Senior Director, Medical Affairs
Capricor Therapeutics